Sign in

CIK 0001857044

  • Non-accelerated filer
  • Smaller reporting company

Indaptus Therapeutics, Inc.

Sign in to watch
Ticker
INDP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863158720
Phone
+1 646-427-2727
Business address
3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
Former names
Intec Parent Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-06-10 Gilbert Mark John Director Grant or award · Stock Option (right to buy) +12,500 12,500
2024-06-06 Gilbert Mark John Director Grant or award · Stock Option (right to buy) +12,500 12,500
2023-05-25 Gilbert Mark John Director Grant or award · Stock Option (right to buy) +12,500 12,500
2022-09-30 Gilbert Mark John Director Grant or award · Stock Option (right to buy) +13,750 13,750
2021-12-01 Gilbert Mark John Director Grant or award · Stock Option (right to buy) +20,000 20,000

Page 1 of 1 · 5 trades